January 2017 Issue Table Of Contents

From The Editor

• What You Need To Know About Being Ready To Join A Board

Feature Articles

• Janssen Immunology — Science & Market Drivers
• Inside Takeda Oncology’s Patient Advocacy Program

Capitol Perspectives

• Risks And Rewards Of Repeal And Replace

Companies To Watch

• Ritter Pharmaceuticals

CEO Corner

• An Insider’s View Of Life Outside The Academic Gilded Cage

Inside The Industry

• Why Pet Health Is The Focus Of A New Biotech Sector
• How Boehringer Ingelheim Is Redefining Its R&D Strategy
• Cell Therapy Regulations Approach Their Inflection Point
• Orphan Drug Incentives & Innovations On The Rise
• Biotech Bounces Back: A Tale Of Two Companies
• Janssen Uses Trial Simulations To Capture Patient Concerns
• Beyond Oncology — Precision Medicine For Autoimmune Diseases

Leadership Lessons

• The Best Way To Set Goals In The New Year

Industry Leader

• Meeting The Unknown Need In Pharma Labs
• How To Increase Productivity Via Unconventional Hiring

Ask The Board

• How Do You Answer The Question Of A Centralized Or Decentralized Processing Location For Personalized Medicine Purposes?
• What Are Some Key Considerations When Adopting Technologies To Enhance Clinical Trials?
• Knowing What You Know Now, What Would You Not Do Differently?